Premium
Significant improvement in overall survival among patients diagnosed with low‐risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors
Author(s) -
Li Ang,
Yellapragada Sarvari V.,
Mims Martha,
Frolov Anna,
Rivero Gustavo A.
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14031
Subject(s) - medicine , serotonin uptake inhibitors , myelodysplastic syndromes , oncology , serotonin , reuptake inhibitor , fluoxetine , bone marrow , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom